Adjuvant Trastuzumab Is Required in Human Epidermal Growth Factor Receptor 2-Positive Node-Negative Breast Cancer Patients Regardless of Tumour Size

Detalles Bibliográficos
Autores principales: Bender, Laura, Kurtz, Jean-Emmanuel, Petit, Thierry, Pivot, Xavier
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Korean Breast Cancer Society 2020
Materias:
Letter to the Editor
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7779725/
https://www.ncbi.nlm.nih.gov/pubmed/33408893
http://dx.doi.org/10.4048/jbc.2020.23.e62

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7779725/
https://www.ncbi.nlm.nih.gov/pubmed/33408893
http://dx.doi.org/10.4048/jbc.2020.23.e62

Ejemplares similares